After matching, the FM and IM cohorts (28,269 vs. 28,269) had similar ages and overall comorbidities, but the IM cohort had a higher initial prescription of insulin by 0.15 times/month and a higher annual diabetes-related cost of USD 20. This evidence concerns the gene INS and diabetes mellitus.